430 related articles for article (PubMed ID: 16319195)
21. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.
Paulus C; Krauss S; Nevels M
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3840-5. PubMed ID: 16497831
[TBL] [Abstract][Full Text] [Related]
22. The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling.
Gotoh B; Takeuchi K; Komatsu T; Yokoo J
J Virol; 2003 Mar; 77(6):3360-70. PubMed ID: 12610111
[TBL] [Abstract][Full Text] [Related]
23. A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses.
Michalska A; Blaszczyk K; Wesoly J; Bluyssen HAR
Front Immunol; 2018; 9():1135. PubMed ID: 29892288
[TBL] [Abstract][Full Text] [Related]
24. [A novel molecular mechanism of interferon alpha-regulated expression of retinoic acid-induced gene G].
Lou YJ; Pan XR; Jia PM; Li D; Zhang ZL; Xu GP; Tong JH
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):88-92. PubMed ID: 20403236
[TBL] [Abstract][Full Text] [Related]
25. The role of signal transducer and activator of transcription-2 in the interferon response.
Steen HC; Gamero AM
J Interferon Cytokine Res; 2012 Mar; 32(3):103-10. PubMed ID: 22280068
[TBL] [Abstract][Full Text] [Related]
26. Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL-positive cells to interferon alpha.
Schubert C; Allhoff M; Tillmann S; Maié T; Costa IG; Lipka DB; Schemionek M; Feldberg K; Baumeister J; Brümmendorf TH; Chatain N; Koschmieder S
J Hematol Oncol; 2019 Apr; 12(1):36. PubMed ID: 30940163
[TBL] [Abstract][Full Text] [Related]
27. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
[TBL] [Abstract][Full Text] [Related]
28. Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs.
Abdul-Sater AA; Majoros A; Plumlee CR; Perry S; Gu AD; Lee C; Shresta S; Decker T; Schindler C
J Immunol; 2015 Jul; 195(1):210-216. PubMed ID: 26019270
[TBL] [Abstract][Full Text] [Related]
29. [Gene expression profile in K562 cells treated by interferon alpha].
Wu B; Zhou SY; Liu XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):746-50. PubMed ID: 16277835
[TBL] [Abstract][Full Text] [Related]
30. A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells.
Lynch RA; Etchin J; Battle TE; Frank DA
Cancer Res; 2007 Feb; 67(3):1254-61. PubMed ID: 17283162
[TBL] [Abstract][Full Text] [Related]
31. Isolation and activity of the promoters for STAT1 and 2 in Atlantic salmon Salmo salar.
Collins C; Ganne G; Collet B
Fish Shellfish Immunol; 2014 Oct; 40(2):644-7. PubMed ID: 25128593
[TBL] [Abstract][Full Text] [Related]
32. Apical role for BRG1 in cytokine-induced promoter assembly.
Ni Z; Karaskov E; Yu T; Callaghan SM; Der S; Park DS; Xu Z; Pattenden SG; Bremner R
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14611-6. PubMed ID: 16195385
[TBL] [Abstract][Full Text] [Related]
33. The non-pathogenic Henipavirus Cedar paramyxovirus phosphoprotein has a compromised ability to target STAT1 and STAT2.
Lieu KG; Marsh GA; Wang LF; Netter HJ
Antiviral Res; 2015 Dec; 124():69-76. PubMed ID: 26526590
[TBL] [Abstract][Full Text] [Related]
34. PCBP2 enhances the antiviral activity of IFN-α against HCV by stabilizing the mRNA of STAT1 and STAT2.
Xin Z; Han W; Zhao Z; Xia Q; Yin B; Yuan J; Peng X
PLoS One; 2011; 6(10):e25419. PubMed ID: 22022391
[TBL] [Abstract][Full Text] [Related]
35. STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha.
Zimmerer JM; Lesinski GB; Radmacher MD; Ruppert A; Carson WE
Cancer Immunol Immunother; 2007 Nov; 56(11):1845-52. PubMed ID: 17503042
[TBL] [Abstract][Full Text] [Related]
36. p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.
Testoni B; Schinzari V; Guerrieri F; Gerbal-Chaloin S; Blandino G; Levrero M
Oncogene; 2011 Jun; 30(23):2670-8. PubMed ID: 21399658
[TBL] [Abstract][Full Text] [Related]
37. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation.
Stancato LF; David M; Carter-Su C; Larner AC; Pratt WB
J Biol Chem; 1996 Feb; 271(8):4134-7. PubMed ID: 8626752
[TBL] [Abstract][Full Text] [Related]
38. CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells.
Urin V; Shemesh M; Schreiber G
J Mol Biol; 2019 Aug; 431(17):3324-3338. PubMed ID: 31207241
[TBL] [Abstract][Full Text] [Related]
39. Mapping the chromosomal targets of STAT1 by Sequence Tag Analysis of Genomic Enrichment (STAGE).
Bhinge AA; Kim J; Euskirchen GM; Snyder M; Iyer VR
Genome Res; 2007 Jun; 17(6):910-6. PubMed ID: 17568006
[TBL] [Abstract][Full Text] [Related]
40. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors.
Takauji R; Iho S; Takatsuka H; Yamamoto S; Takahashi T; Kitagawa H; Iwasaki H; Iida R; Yokochi T; Matsuki T
J Leukoc Biol; 2002 Nov; 72(5):1011-9. PubMed ID: 12429724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
